<p>In this edition of The Healthcare Revolution podcast, MHK President Marc S. Ryan examines the recent controversy over the approval of Aduhelm and the backtracking the government did on coverage of the drug in Medicare. It is a microcosm about what is wrong with our drug approval and pricing process.</p>

In this edition of The Healthcare Revolution podcast, MHK President Marc S. Ryan examines the recent controversy over the approval of Aduhelm and the backtracking the government did on coverage of the drug in Medicare. It is a microcosm about what is wrong with our drug approval and pricing process.

Aduhelm and the Microcosm of What is Wrong with our Drug Approval and Pricing Process

Welcome to The Healthcare Revolution podcast with MHK, brought to you by Marc S. Ryan, MHK president. MHK is a leading healthcare software technology firm serving health plans, pharmacy benefit managers, and other managed care organizations. MHK is on the cutting edge of healthcare transformation and Marc offers his insights on the evolving healthcare landscape in this thought-provoking podcast.

Share Aduhelm and the Microcosm of What is Wrong with our Drug Approval and Pricing Process

Sign up to save your podcasts

Aduhelm and the Microcosm of What is Wrong with our Drug Approval and Pricing Process

Aduhelm and the Microcosm of What is Wrong with our Drug Approval and Pricing Process